NCT04046133
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04046133
Title Phase 1b/II Trial of Pembrolizumab Plus IMRT in Stage III/IV Carcinoma of Anus (CORINTH)
Acronym CORINTH
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Cardiff University
Indications
Therapies
Age Groups: adult | senior
Covered Countries NOR | GBR

Facility Status City State Zip Country Details
Oslo University Hospital Oslo NO-0424 Norway Details
Aberdeen Royal Informary Aberdeen Scotland AB25 2ZN United Kingdom Details
Cambridge University Hospitals NHS Foundation Trust Cambridge United Kingdom Details
Velindre Cancer Centre Cardiff United Kingdom Details
East Suffolk and North Essex NHS Foundation Trust Colchester United Kingdom Details
The Leeds Teaching Hospitals NHS Trust Leeds United Kingdom Details
The Christie NHS Foundation Trust Manchester United Kingdom Details
Mount Vernon Cancer Centre Northwood HA6 2RN United Kingdom Details
Oxford University Hospitals NHS Foundation Trust Oxford United Kingdom Details
Sheffield Teaching Hospitals NHS Foundation Trust Sheffield United Kingdom Details
Swansea Bay University Local Health Board Swansea United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field